Discover 298 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Idaho provides a wide range of paid clinical research opportunities for both healthy volunteers and people with specific health conditions. Facilities in Boise, Idaho Falls, and Meridian are actively seeking participants, offering access to new therapies and specialized care.
Filter
1
Filter results
Results: 298
Active & Responsive
Long-Term Outcomes Following HBOT
for
Traumatic Brain Injury, Post-Concussive Symptoms,
Location: Boise ID
Sponsor: Summit Hyperbarics and Wellness
Sex: All
Age: 18+
Code: NCT07732374
Phase 2, Recruiting
Active & Responsive
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
for
Primary Sjogren's Disease
Location: Boston MA, Philadelphia PA, Willow Grove PA,
Sponsor: Vor Biopharma
Sex: All
Age: 18 - 70+
Code: NCT07404865
Phase 3, Recruiting
Active & Responsive
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient Disorders
for
Turner Syndrome, Short Stature Homeobox Gene Mutation,
Location: Lake Success NY, Wilmington DE, Washington D.C. DC,
Sponsor: Ascendis Pharma A/S
Sex: All
Age: 2 - 17
Code: NCT07221851
Phase 3, Recruiting
Active & Responsive
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Patchogue NY, Stony Brook NY, Berlin Corners VT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase 3, Recruiting
Active & Responsive
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06963827
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
Location: Augusta ME, Boston MA, Providence RI, Concord NH,
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: Boston MA, Providence RI, Hartford CT, New Haven CT,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT00736749
Recruiting
New
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
for
Diabetes Mellitus, Type 2
Location: Stamford CT, The Bronx NY, Smithfield PA, Decatur GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 10 - 17
Code: NCT07668336
Phase 3, Recruiting
New
Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Manchester NH, Concord NH, Saint Johnsbury VT,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT07393555
Phase 2, Recruiting
New
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
for
Type 1 Diabetes, Type 2 Diabetes
Location: Charlottesville VA, Atlanta GA, Austin TX,
Sponsor: Medtronic MiniMed, Inc.
Sex: All
Age: 2 - 70+
Code: NCT07864168
Recruiting
New
A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for
Uncontrolled Gout
Location: Hamilton NJ, Columbia MD, Oxon Hill MD, Richmond VA,
Sponsor: Amgen
Sex: All
Age: 18+
Code: NCT07388498
Phase 3, Recruiting
Safety and Effectiveness of the Yaari Extractor for Management of Shoulder Dystocia
for
Shoulder Dystocia
Location: Falls Church VA, Winston-Salem NC, Miami FL,
Sponsor: FetalEase Ltd.
Sex: Female
Age: 18+
Code: NCT05913609
Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
A Study to Assess Growth in Children With Idiopathic Short Stature
for
Idiopathic Short Stature
Location: Hartford CT, Lebanon NH, Garden City NY, The Bronx NY,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 2 - 16
Code: NCT06309979
Recruiting
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures